This month, 19% of respondents say they are currently using or are interested in taking a GLP-1 medication for weight loss purposes
Arq Bras.Endocrinol.Metabol
Those who are comfortable self-administering an injection or visiting a clinic for it may lean toward this option
GLP-1 receptor agonists (such as exenatide, liraglutide, dulaglutide, and semaglutide) commonly cause nausea, vomiting, and abdominal discomfort, particularly during the initial weeks of treatment
Using injectables can feel invasive and not desired
They have announced new manufacturing sites to be developed in Pennsylvania, 6 Texas, 7 and Alabama